Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive perspective. Proponents often highlight the potential for substantial therapeutic outcomes, principally in conditions where conventional therapies have proven ineffective. However, this is to evaluate the significant financial burden associated with CPI stem cell